Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,638 papers from all fields of science
Search
Sign In
Create Free Account
Oxyphenbutazone
Known as:
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
, Oxyphenbutazone [Chemical/Ingredient]
, Hydroxyphenylbutazone
Expand
A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Narrower (3)
4-hydroxyphenylbutazone
Tanderil
kymalzone
Broader (1)
Anti-Inflammatory Agents, Non-Steroidal
In Blood
Oxyphenbutazone:MCnc:Pt:Bld:Qn
Oxyphenbutazone:MCnc:Pt:Ser/Plas:Qn
Oxyphenbutazone:Mass:Pt:Dose:Qn
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma…
Senee Yingprasertchai
,
Srisurat Bunyasrisawat
,
K. Ratanabanangkoon
Toxicon
2003
Corpus ID: 23495601
Highly Cited
2003
Highly Cited
2003
Analysis of adulterants in a traditional herbal medicinal product using liquid chromatography-mass spectrometry-mass spectrometry.
A. Lau
,
M. Holmes
,
S. Woo
,
H. Koh
Journal of Pharmaceutical and Biomedical Analysis
2003
Corpus ID: 41711486
Highly Cited
1986
Highly Cited
1986
Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
Journal of the American Medical Association (JAMA…
1986
Corpus ID: 23541103
Highly Cited
1979
Highly Cited
1979
Anti-inflammatory drugs in experimental atherosclerosis. Part 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vitro.
J. Bailey
,
A. Makheja
,
J. Butler
,
K. Salata
Atherosclerosis
1979
Corpus ID: 43017641
Review
1977
Review
1977
Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
W. Inman
British medical journal
1977
Corpus ID: 57660353
The histories of 269 patients whose death certificates did not mention a drug as the cause of aplastic anaemia or agranulocytosis…
Expand
Highly Cited
1975
Highly Cited
1975
Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin‐alcohol
Gillian Sudlow
,
D. Birkett
,
D. Wade
Clinical and Experimental Pharmacology and…
1975
Corpus ID: 23377657
1. The binding of racemic mixtures of warfarin and warfarin‐alcohol to human serum albumin (HSA) is accompanied by an increase in…
Expand
Highly Cited
1969
Highly Cited
1969
A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man
W. Hammer
,
Sten Mårtens
,
F. Sjöqvist
Clinical pharmacology and therapy
1969
Corpus ID: 42104785
The steady‐state plasma levels of desmethylimipramine and nortriptyline were compared with the half‐life of oxyphenylbutazone in…
Expand
Highly Cited
1968
Highly Cited
1968
Induction of collagenolytic and proteolytic activities by anti-inflammatory drugs in the skin and fibroblast.
J. Houck
,
V. Sharma
,
Y. M. Patel
,
J. Gladner
Biochemical Pharmacology
1968
Corpus ID: 38807497
Highly Cited
1967
Highly Cited
1967
Treatment of sarcoidosis. Report of a controlled therapeutic trial.
D. James
,
L. Carstairs
,
J. Trowell
,
O. P. Sharma
The Lancet
1967
Corpus ID: 46594823
Highly Cited
1964
Highly Cited
1964
BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
H. Bostroem
,
K. Berntsen
,
M. Whitehouse
Biochemical Pharmacology
1964
Corpus ID: 33912025
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required